Skilled nursing bed prices increase by 4% in 2009, report finds

Editors' Blog: Targeting Medicaid
Editors' Blog: Targeting Medicaid

The average price per bed for skilled nursing facilities rose slightly in 2009, while the price per bed in assisted living facilities fell, according to the 15th edition of the Senior Care Acquisition Report from Irving Levin Associates Inc.

In 2009, prices increased by 4%, climbing to $47,500 per bed, according to the report. The increase is more likely a sign of market stabilization than of a rebound, according to report editor Stephen M. Monroe. During the economic collapse in 2008, the price per bed in skilled nursing fell roughly 18%.The weak housing market did not have a significant impact on skilled nursing last year, and average capitalization rates in 2009 for skilled nursing facilities remained at 12.8%, according to the report.

Assisted living facilities, however, took a hit from the housing market in 2009, as rates fell 9% to an average price of $113,300 per unit. More information can be found at http://www.levinassociates.com/scardescription.

More in News

Experts tell lawmakers: Obama Medicare proposals would hurt long-term care — or maybe not

Experts tell lawmakers: Obama Medicare proposals would hurt ...

U.S. lawmakers heard mixed messages at a hearing Tuesday on how proposed Medicare cost-sharing reforms would impact long-term care. The House Ways and Means Subcommittee on Health focused in particular ...

Nursing home administrators can rise to 'unrealistic expectations' with disaster management, expert ...

One day after a powerful tornado destroyed a hospital and devastated an Oklahoma town, long-term care stakeholders gathered at a disaster preparedness conference organized by the Center for Preparedness Education, a joint endeavor of the Creighton University School of Medicine and the University of Nebraska ...

Long-term care physicians respond to report on antipsychotic over-prescribing

The top professional association of long-term care physicians and medical directors has reiterated its commitment to reducing the use of antipsychotics for dementia care. It did so Tuesday, in response to a recent report that criticized prescribing practices.